Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert Landewé, Sofía Ramiro, Désirée van der Heijde, Elena Nikiphorou
Topics & Concepts
MedicineSecukinumabUstekinumabObservational studyEtanerceptGolimumabInternal medicineCertolizumab pegolIxekizumabCanakinumabPhysical therapyAnakinraAnkylosing spondylitisInfliximabAdalimumabRandomized controlled trialPsoriatic arthritisDiseaseTumor necrosis factor alphaSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research